News Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse Staff September 11, 2023 Iframe sync Post navigation Previous: APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next: Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer More Stories Healthcare News Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth Staff February 1, 2026 Healthcare News Patient Care AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai Staff February 1, 2026 Healthcare News Patient Care Pharmaceutical AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research Staff January 31, 2026
